MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$6,496K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Proceeds from long-term debt
Proceeds from insurance recovery...
Others
Negative Cash Flow Breakdown
Repayment of long-term debt
Accounts payable
Insurance recovery on property, ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net income
14,524
10,738
Stock-based compensation
1,326
4,697
Depreciation and amortization
3,594
7,387
Assets write-down
0
34
Inventory write-off and obsolescence
809
1,620
Provision for credit losses
549
1,603
Changes in value of life insurance policies
1,017
834
Deferred income taxes
1,406
3,167
Insurance recovery on property, plant and equipment
5,273
1,557
Other non-cash items
-286
-566
Accounts receivable
-3,102
3,717
Inventories
-723
1,991
Prepaid expenses and other current assets
-20
817
Other assets
242
109
Accounts payable
-5,363
6,647
Accrued expenses
-2,484
-886
Unearned revenues
-1,856
-218
Other liabilities
1,210
587
Net cash provided by operating activities
8,502
20,583
Capital expenditures - operations
2,006
6,259
Capital expenditures - rebuilding of aberdeen facility
1,024
1,648
Proceeds from insurance recovery - aberdeen facility
5,273
4,678
Patents and other intangibles
2
0
Acquisitions, net of cash acquired
0
617
Proceeds from sale of assets
152
2,196
Net proceeds on life insurance policies
0
-778
Net cash provided by (used in) investing activities
2,393
-872
Repayment of long-term debt
20,000
27,000
Proceeds from long-term debt
11,000
25,000
Debt issuance costs
1,706
-
Dividends paid
465
938
Repurchase of common stock
5,009
4,761
Equity related transaction costs
0
0
Other financing activity
-274
19
Net cash used in financing activities
-16,454
-7,680
Net change in cash and cash equivalents
-5,559
12,031
Cash and cash equivalents at beginning of period
19,157
-
Cash and cash equivalents at end of period
25,629
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$14,524K
Proceeds from insurance
recovery - aberdeen...
$5,273K
Depreciation and
amortization
$3,594K
Accounts receivable
-$3,102K
Stock-based compensation
$1,326K
Other liabilities
$1,210K
Inventory write-off and
obsolescence
$809K
Inventories
-$723K
Provision for credit
losses
$549K
Other non-cash items
-$286K
Prepaid expenses and
other current assets
-$20K
Proceeds from sale of
assets
$152K
Net cash provided by
operating activities
$8,502K
Net cash provided by
(used in) investing...
$2,393K
Canceled cashflow
$17,641K
Canceled cashflow
$3,032K
Net change in cash
and cash...
-$5,559K
Canceled cashflow
$10,895K
Proceeds from long-term
debt
$11,000K
Accounts payable
-$5,363K
Insurance recovery on
property, plant and...
$5,273K
Accrued expenses
-$2,484K
Unearned revenues
-$1,856K
Deferred income taxes
$1,406K
Changes in value of life
insurance policies
$1,017K
Other assets
$242K
Capital expenditures -
operations
$2,006K
Capital expenditures -
rebuilding of aberdeen...
$1,024K
Patents and other
intangibles
$2K
Net cash used in
financing activities
-$16,454K
Canceled cashflow
$11,000K
Repayment of long-term
debt
$20,000K
Repurchase of common stock
$5,009K
Debt issuance costs
$1,706K
Dividends paid
$465K
Other financing
activity
-$274K
Buy us a coffee
Core Laboratories Inc. DE (CLB)
Core Laboratories Inc. DE (CLB)